Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.
Clinical trial NCT07570563 · RECRUITING
Trial details
- NCT number
- NCT07570563
- Sponsor
- Chinese PLA General Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2029-06-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.